Therapeutic time window for angiotensin-(1-7) in acute lung injury-Reference-Cited by-同舟云学术

Therapeutic time window for angiotensin-(1-7) in acute lung injury

Published:2016-03-21 Issue:10 Volume:173 Page:1618-1628
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Supé Stefanie¹,Kohse Franziska¹²,Gembardt Florian³⁴,Kuebler Wolfgang M¹⁵⁶⁷,Walther Thomas⁸⁹

Affiliation:

1. Institute of Physiology; Charité-Universitätsmedizin Berlin; Berlin Germany

2. Center for Perinatal Medicine, Clinic of Paediatric Surgery; University of Leipzig; Leipzig Germany

3. Department of Cardiac Pathobiology; Excellence Cluster Cardiopulmonary System; Gießen Germany

4. Department of Nephrology-MK3; University Hospital Dresden; Dresden Germany

5. Keenan Research Centre for Biomedical Science; St Michael‘s Hospital; Toronto ON Canada

6. Departments of Physiology and Surgery; University of Toronto; Ontario Canada

7. German Heart Institute; Berlin Germany

8. Department of Pharmacology and Therapeutics; University College Cork; Cork Ireland

9. Center for Perinatal Medicine, Department of Obstetrics; University of Leipzig; Leipzig Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13462/fullpdf

Reference43 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015a

2. The Concise Guide to PHARMACOLOGY 2015/16: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2015b

3. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial;Balingit;Wound Repair Regen,2012

4. Pharmacological treatments in ARDS; a state-of-the-art update;Boyle;BMC Med,2013

5. Inhaled milrinone attenuates experimental acute lung injury;Bueltmann;Intensive Care Med,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury;Clinical and Translational Medicine;2024-08

2. Role of the RAAS in mediating the pathophysiology of COVID-19;Pharmacological Reports;2024-04-23

3. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?;Frontiers in Pharmacology;2024-04-10

4. The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection;Journal of the Renin-Angiotensin-Aldosterone System;2022-05-27

5. Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice;International Journal of Molecular Sciences;2022-03-26